Investor Alert

Company Close Updates Archives | Email alerts

June 4, 2021, 5:00 p.m. EDT

Incyte Corp. stock rises Friday, still underperforms market

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Incyte Corp. INCY inched 0.52% higher to $83.33 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.88% to 4,229.89 and the Dow Jones Industrial Average DJIA rising 0.52% to 34,756.39. This was the stock's second consecutive day of gains. Incyte Corp. closed $27.04 short of its 52-week high ($110.37), which the company achieved on July 7th.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Pfizer Inc. PFE rose 0.46% to $39.15, Novartis AG ADR NVS rose 0.55% to $89.80, and Eli Lilly & Co. LLY fell 0.34% to $202.02. Trading volume (1.0 M) remained 77,198 below its 50-day average volume of 1.1 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Incyte Corp. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.